Cargando…
RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families
BACKGROUND: In more than 70% of families with a strong history of breast and ovarian cancers, pathogenic mutation in BRCA1 or BRCA2 cannot be identified, even though hereditary factors are expected to be involved. It has been proposed that tumors with similar molecular phenotypes also share similar...
Autores principales: | Larsen, Martin J, Thomassen, Mads, Tan, Qihua, Lænkholm, Anne-Vibeke, Bak, Martin, Sørensen, Kristina P, Andersen, Mette Klarskov, Kruse, Torben A, Gerdes, Anne-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909442/ https://www.ncbi.nlm.nih.gov/pubmed/24479546 http://dx.doi.org/10.1186/1755-8794-7-9 |
Ejemplares similares
-
Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling
por: Larsen, Martin J., et al.
Publicado: (2013) -
Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness
por: Andersen, Lars v. B., et al.
Publicado: (2023) -
Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data
por: Krøigård, Anne Bruun, et al.
Publicado: (2016) -
Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence
por: Krøigård, Anne Bruun, et al.
Publicado: (2017) -
Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis
por: Krøigård, Anne Bruun, et al.
Publicado: (2015)